Protagonist Therapeutics, Inc. (PTGX)
NASDAQ·Healthcare·Biotechnology
$132.61
+0.44%
Mkt Cap $8.54B
Analyst Ratings
Buy
14
Hold
0
Sell
0
Price Target (28 analysts)
$176.29
Range $165.00 – $190.00
Implied Upside
+32.9%
Consensus $176.29 vs current $132.61